Federal tax exposure and regulatory uncertainty remain defining risks for the cannabis industry. New financial analysis shows disputed liabilities continuing to grow, while the DEA is resisting another potential delay in marijuana rescheduling and Los Angeles is tightening rules for cannabis retailers.
Cannabis Companies Report $2.82 Billion in Uncertain Tax Liabilities
Fifteen publicly traded marijuana companies reported a combined $2.82 billion in uncertain tax liabilities as of June 30, according to an examination of corporate financial disclosures. The total increased by approximately $47.3 million during the first half of 2026, with 12 of the 15 companies reporting higher balances.
The liabilities largely reflect disputed positions involving Internal Revenue Code Section 280E. Although qualifying medical cannabis activity received prospective relief following federal rescheduling in April, companies continue to carry substantial reserves tied to adult-use operations, earlier tax periods and unresolved claims under examination by tax authorities.
Why It Matters: Analysis: These balances represent a major contingent risk for operators, investors and potential acquirers. Until federal agencies clarify retroactive relief and resolve disputed filings, tax exposure could continue to influence cash management, financing terms, valuations and cannabis-sector consolidation.
Source: The Marijuana Herald
DEA Opposes Additional Briefing in Marijuana Rescheduling Case
The Drug Enforcement Administration is not objecting to a judge deciding whether to add a Government Accountability Office report to the marijuana rescheduling hearing record. The agency is opposing requests for additional briefing, however, arguing that the report does not bear on whether marijuana should be transferred to Schedule III.
Anti-rescheduling participants have sought to use the GAO report, which identified gaps in federal drug-scheduling policies, to reopen arguments and potentially expand testimony and document discovery. Chief Administrative Law Judge Derek Julius must now decide whether to admit the report and whether any additional proceedings are warranted.
Why It Matters: Analysis: The ruling could determine whether the rescheduling process resumes toward a recommended decision or enters another extended procedural phase. For cannabis businesses, the timing affects tax planning, investment decisions and expectations for broader federal reform.
Source: Cannabis Business Times
Los Angeles Criminalizes Nitrous Oxide Sales by Cannabis Retailers
The Los Angeles City Council approved an ordinance prohibiting cannabis and tobacco retailers from selling or distributing nitrous oxide. Mayor Karen Bass intends to sign the measure, which is expected to take effect approximately one month after signing.
Unlike related California restrictions that treat violations as infractions, the Los Angeles ordinance makes a violation a misdemeanor punishable by a fine of up to $1,000, as much as six months in jail, or both. City officials advanced the measure amid concerns about recreational nitrous oxide use and associated injuries and deaths.
Why It Matters: Analysis: Cannabis retailers operating in Los Angeles will need to review inventories, vendor relationships and employee compliance procedures. The possibility of criminal penalties makes the ordinance a substantially greater enforcement risk than a conventional product restriction.
Source: Los Angeles Times
What We’re Watching
Over the next 24 to 72 hours, watch for an order from the DEA administrative law judge on the GAO report, responses from cannabis operators to the industry’s growing tax exposure and additional implementation guidance from Los Angeles as the nitrous oxide ordinance moves toward the mayor’s signature.
